2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
5
Neoplasm Metastasis
4
Multiple Myeloma
2
Sarcoma, Ewing
1
Osteoporotic Fractures
1
Osteoporosis
1
Neoplastic Cells, Circulating
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Musculoskeletal Pain
1
Clear-cell metastatic renal cell carcinoma
1
Carcinoma, Renal Cell
1
Arthralgia
1
Interventions
Blood Specimen Collection
29
Reverse Transcriptase Polymerase Chain Reaction
7
Flow Cytometry
7
Surgical Procedures, Operative
4
Liquid Biopsy
4
cabazitaxel
3
Trastuzumab
3
Propofol
3
Carboplatin
3
Bevacizumab
3
Standard of Care
2
Spinal Puncture
2
Sevoflurane
2
Positron Emission Tomography Computed Tomography
2
Pirinitramide
2
Neoadjuvant Therapy
2
Morphine
2
Laparoscopy
2
Hematologic Tests
2
Gemcitabine
2
Folfox protocol
2
Epirubicin
2
Drug Therapy
2
Docetaxel
2
Cyclophosphamide
2
Cisplatin
2
Cetuximab
2
Capecitabine
2
Aspirin
2
Anesthesia, General
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplastic Cells, Circulating
×
Diphosphonates
×
Clear all
NCT01129336
2014-05-20
MACS1295
Novartis
Phase 4
Completed
44 enrolled
10 charts